Challenging Cases - Treatment of Renal Cell Carcinoma (RCC): Dr. Pedro Barata

Welcome to the Oncology Brothers podcast! In this episode, we dived into a challenging case series focused on kidney cancer, featuring special guest Dr. Pedro Barata, a GU medical oncologist from the University Hospitals.We had the opportunity to explore two real-life cases that highlighted the complexities of treatment decisions in metastatic renal cell carcinoma (RCC). We discussed the latest frontline options, including immunotherapy and targeted therapy combinations, and how to choose the best approach based on patient characteristics and disease progression.Key topics covered in this episode included:The role of next-generation sequencing (NGS) in guiding treatment optionsChoosing between dual checkpoint inhibitors and IO-TKI combinationsManaging side effects associated with various treatment regimensSequencing treatment options for patients who progress after initial therapyInsights into the latest data on emerging therapies like Belzutifan and LenvatinibListen us on:Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media:X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/Don't forget to like, subscribe, and check out our other episodes for more challenging case discussions and treatment algorithms!#KidneyCancer, #RenalCellCarcinoma, #RCC, #Immunotherapy, #TKI,#OncologyBrothers